Home / Program / Scientific Sessions

Scientific Sessions

Twenty-five tracks across clinical practice, neuroscience and policy. Submissions are accepted against any of them until 15 October 2026.

The list below is fixed before submissions open, which is why it is broad. Roughly the first half is clinical, the second half neuroscientific, and policy and service questions run through both. Pick the track your work genuinely belongs to rather than the nearest available label — fit is one of the three things reviewers score, and a good abstract attached to the wrong session is the most common avoidable rejection.

The two presentations that account for more clinical contact than any others, and where the distance between best evidence and routine care is widest. This track looks at what shortens the road to remission.

Areas of focus

  • Sequencing treatment when the first attempt only partly works
  • Advances in antidepressant and anxiolytic prescribing
  • Behavioural activation in short-appointment settings
  • Mindfulness-based approaches and their boundaries
  • Keeping people well after recovery

Trauma-focused treatment across civilian, veteran and occupational populations, and how services organise themselves to deliver it without long waits.

Areas of focus

●  Trauma-focused CBT and EMDR in routine services

●  Complex and developmental presentations

●  Pharmacological adjuncts and their limits

●  Moral injury among healthcare staff

●  Outcome measurement outside trial conditions

Early intervention, school-based provision and the developmental factors that change how a presentation looks and how it responds to treatment.

Areas of focus

●  Identification in schools and primary care

●  Working with families rather than around them

●  Social media and adolescent wellbeing

●  The transition from child to adult services

●  Keeping young people engaged in treatment

What employers can actually change, separated from what merely looks supportive. Evidence on workload, psychological safety and return-to-work.

Areas of focus

●  Assessing psychosocial risk

●  Manager training and what it does not fix

●  Structured return-to-work planning

●  Burnout in frontline and healthcare roles

●  Evaluating employer wellbeing programmes

Treating addiction and mental illness together rather than passing patients between services, and the models that make integration possible.

Areas of focus

●  Integrated versus parallel treatment

●  Medication-assisted treatment in practice

●  Harm reduction in mainstream settings

●  Screening in general mental health services

●  Coordination and follow-up after discharge

Presentations, treatment considerations and evidence gaps across the reproductive lifespan.

Areas of focus

●  Perinatal mental health services
●  Hormonal influences on mood
●  Trauma-informed care in practice
●  Access and equity in treatment
●  Sex differences in study design

Assessment and treatment in older adults, where cognition, physical illness and prescribing interact and rarely present cleanly.

Areas of focus

●  Late-life depression and anxiety
●  Telling delirium, depression and dementia apart
●  Reviewing polypharmacy
●  Isolation and loneliness as clinical factors
●  Capacity and goals-of-care conversations

Treatment gaps between and within countries, and the delivery models built to close them where specialist workforce is scarce.

Areas of focus

●  Task-sharing and lay counsellor programmes

●  Financing and workforce shortages

●  Cultural adaptation of interventions

●  Humanitarian and displacement settings

●  Measuring equity rather than coverage

A clinical and public health track on prevention frameworks, crisis service design and support afterwards. Presentations follow safe-reporting standards for professional audiences.

Areas of focus

●  Risk assessment frameworks and their evidence base
●  Crisis line and crisis team service models
●  Collaborative safety planning
●  Postvention and support for bereaved families
●  Supervision and staff support

Apps, teletherapy, remote monitoring and AI-assisted tools, and the standard of evidence they should be held to before entering a care pathway.

Areas of focus

●  Evidence thresholds for digital therapeutics

●   Teletherapy outcomes and dropout

●   AI-assisted triage and documentation

●  Consent, privacy and data governance

●   Digital exclusion among the people most likely to need care

What contemplative interventions achieve, what they do not, and where they belong alongside established treatment.

Areas of focus

●   The MBSR and MBCT evidence base

●   Resilience training in organisations

●   Adverse effects and contraindications

●   Delivering at scale without diluting

●    Mechanisms and measurement

Legislation, coercion, advocacy and the international frameworks that shape what services are permitted and expected to do.

Areas of focus

●   Rights-based mental health legislation

●   Reducing coercive practice

●   Service user and carer involvement

●   Parity of esteem in funding decisions

●   Evaluating policy after implementation

Identification, evidence-based treatment and service pathways. Presentations follow safe-reporting standards and omit detail that would be unsafe outside a clinical setting.

Areas of focus

●   Screening and early identification

●  Family-based and psychological treatments

●   Medical monitoring and multidisciplinary working

●   Body image in clinical and public health contexts

●   Follow-up and relapse prevention

Sleep and mental illness each worsen the other. This track covers treating both rather than one and hoping.

Areas of focus

●  CBT for insomnia in mental health services

●  Sleep in mood and psychotic disorders

●  Circadian disruption and shift work

●  Assessment without a sleep laboratory

●  Prescribing, and deprescribing, hypnotics

Autism, ADHD and other neurodevelopmental presentations in adults and children, and how services adapt to them.

Areas of focus

●  Adult diagnosis and assessment pathways

●  Co-occurring mental illness

●  Adapting therapy for neurodivergent clients

●  Workplace and educational adjustment

●  Participatory research practice

The interaction between chronic stress, neuroinflammation and neurodegenerative processes.

Areas of focus

●  Stress pathways and neuroinflammation

●  Caregiver burden and support

●  Early markers and risk reduction

●  Behavioural and psychological symptoms

●  Trial design in slow-progressing disease

The psychiatric and cognitive consequences of neurological disease, and how liaison across specialties works in practice.

Areas of focus

●  Post-stroke depression and apathy
●  Cognitive rehabilitation programmes
●  Psychiatric co-morbidity in epilepsy
●  Neuropsychiatry liaison models
●  Long-term functional outcomes

Neurophysiological tools in diagnosis, prognosis and rehabilitation, and where they change a decision rather than confirm one.

Areas of focus

●  EEG in acute stroke and seizure

●  Prognostic biomarkers

●  Neurophysiology in rehabilitation

●  Quantitative EEG in psychiatry

●  Standardisation and reporting practice

Cognitive mechanisms underlying addiction, and what neuropsychological assessment adds to a treatment plan.

Areas of focus

●  Executive function and craving

●  Cognitive remediation during recovery

●  Assessment in co-occurring disorders

●  Decision-making and relapse risk

●  Translating findings into clinic practice

Diagnosis, disease modification and the psychiatric dimensions of the two most common neurodegenerative conditions.

Areas of focus

●  Biomarkers and earlier diagnosis

●  Disease-modifying therapy: current position

●  Managing neuropsychiatric symptoms

●  Non-motor symptoms in Parkinson’s

●  Supporting care partners

Structural and functional imaging findings, and an honest account of what they have and have not delivered clinically.

Areas of focus

●  Structural and functional MRI findings

●  Connectomics and network models

●  Reproducibility and sample size

●  From group differences to individual prediction

●  Open data and shared pipelines

Mechanisms, emerging targets and the practical realities of prescribing in psychiatry.

Areas of focus

●  Novel mechanisms and targets

●  Psychedelic-assisted therapy research

●  Pharmacogenomics in prescribing

●  Adverse effects and monitoring

●  Deprescribing and polypharmacy

Acquired brain injury, the behavioural changes that follow it, and rehabilitation.

Areas of focus

●  Traumatic brain injury outcomes

●   Behavioural and personality change

●  Concussion in sport and military settings

●  Neurorehabilitation approaches

●   Family and community reintegration

Attention, memory, emotion and decision-making, and how laboratory models translate into clinical ones.

Areas of focus

●  Cognitive models of psychopathology

●  Attention and working memory

●  Emotion regulation research

●  Computational psychiatry

●  Experimental design and replication

Basic science underpinning behaviour, from circuits to systems, and its route toward clinical relevance.

Areas of focus

●  Circuit-level mechanisms

●  Animal models and their limits

●  Gene-environment interaction

●   Developmental neurobiology

●   Translation from bench to bedside